CGT-2026
We cordially invite you to the Global Cell & Gene Therapy Summit-2026, taking place in Boston, MA, from July 6-8, 2026.
- Call Now
- Send Email
-
Address
USG United Scientific Group, A non-profit organization, 8105, Suite 112, Rasor Blvd, Plano, TX 75024, USA
Abstract Submission
Abstract Submission
Topics
- Current Landscape and Future Directions of Cell and Gene Therapy Research
- Advances in Gene Editing Technologies for Cellular Engineering
- Stem Cell-Based Therapies: From Bench to Bedside
- Emerging Gene Therapies for Monogenic Disorders
- Immunotherapy Approaches: CAR-T Cells and Beyond
- Cellular Reprogramming and Regenerative Medicine
- Gene Therapy for Neurodegenerative Diseases: Challenges and Progress
- Non-Viral Gene Delivery Strategies: Enhancing Safety and Efficiency
- Clinical Applications of CRISPR-Cas9: Opportunities and Considerations
- Gene Editing for Hematological Disorders: Promising Results and Ongoing Trials
- Gene Therapy for Rare Diseases: Navigating Orphan Drug Development
- Therapeutic Applications of RNA-Based Therapies
- Gene Therapy Approaches for Cancer Treatment
- CRISPR-Cas9 Advancements: Latest Developments and Applications
- Beyond CRISPR: Emerging Gene Editing Technologies and Techniques
- Gene Therapy Target Identification: From Disease Mechanisms to Therapeutic Targets
- Precision Genome Editing: Strategies for Specific Gene Modifications
- Editing Non-Coding DNA: Implications for Gene Regulation and Disease Treatment
- Gene Editing in Stem Cells: Toward Personalized Cell Therapies
- Gene Delivery Methods: Ensuring Efficient and Safe Editing in Clinical Settings
- Genetic Disease Models: Translating Findings from Bench to Bedside
- Immune System Engineering: Enhancing Cell Therapies through Gene Editing
- Manufacturing Strategies for Global Accessibility of Cell and Gene Therapies
- Process Development and Scale-Up: Challenges and Solutions
- Quality Control and Assurance in Cell and Gene Therapy Manufacturing
- Automation and Robotics in Bioprocessing
- Gene Therapy Vector Production: Advancements and Innovations
- Ensuring Supply Chain Efficiency for Cell and Gene Therapies
- Addressing Logistics Challenges in Cell and Gene Therapy Distribution
- Patient-Specific Manufacturing Approaches: Personalized Medicine at Scale
- GMP Compliance and Regulatory Considerations in Manufacturing
- Developing Next-Generation Manufacturing Technologies
- Contract Manufacturing and Outsourcing Strategies
- Cost Optimization and Affordability in Cell and Gene Therapy Production
- Global Collaboration for Streamlining Manufacturing Processes
- Cell and Gene Therapy Manufacturing Success Stories from Different Regions
- Navigating the Evolving Regulatory Landscape for Cell and Gene Therapies
- Regulatory Pathways for Accelerated Approvals and Expedited Reviews
- Addressing Safety and Efficacy Requirements in Regulatory Submissions
- Risk Management and Pharmacovigilance in Cell and Gene Therapy Trials
- Reimbursement Models for Advanced Therapies: Challenges and Opportunities
- Pricing Strategies and Value-Based Pricing for Cell and Gene Therapies
- Market Entry and Commercialization Planning for Cell and Gene Therapies
- Market Analysis and Forecasting for Advanced Therapy Products
- Building Successful Partnerships with Healthcare Providers and Payers
- Intellectual Property and Patent Strategies in Commercialization
- Case Studies: From Clinical Trials to Market Success